ANIP insider sale: 13,973 shares reported

ANIP: Form 144 filing reporting securities transactions by Patrick Walsh.

Rhea-AI Filing Summary

ANIP: Form 144 filing reporting securities transactions by Patrick Walsh. The filing lists two reported dispositions of Common shares: 10,000 shares sold on 05/13/2026 for $806,300.00 and 3,973 shares sold on 05/11/2026 for $320,819.75. It also lists 4,336 restricted shares dated 05/22/2026 described as "Securities To Be Sold" with issuer indicated as the source.

Insights

Corporate Governance Analyst

Routine insider dispositions reported under Form 144; record of specific sale dates and amounts.

The filing records two open-market or reported sales by Patrick Walsh totaling $1,127,119.75 across two dates in May 2026 and identifies 4,336 restricted shares dated 05/22/2026 listed as securities to be sold by the issuer. Transaction details (method of sale, plan status) are not provided in the excerpt.

These disclosures are compliance-driven under securities resale rules; subsequent filings or broker confirmations would show execution details and any remaining holdings.

Key Figures

Shares sold (05/13/2026): 10,000 shares Proceeds (05/13/2026 sale): $806,300.00 Shares sold (05/11/2026): 3,973 shares +3 more

6 metrics

Shares sold (05/13/2026) 10,000 shares Sold on <date>05/13/2026</date>

Proceeds (05/13/2026 sale) $806,300.00 Receipt reported for 10,000 shares on <date>05/13/2026</date>

Shares sold (05/11/2026) 3,973 shares Sold on <date>05/11/2026</date>

Proceeds (05/11/2026 sale) $320,819.75 Receipt reported for 3,973 shares on <date>05/11/2026</date>

Restricted shares listed 4,336 shares Restricted Stock dated <date>05/22/2026</date> listed as "Securities To Be Sold"

Aggregate reported proceeds $1,127,119.75 Sum of the two reported sale proceeds in May 2026

Key Terms

Form 144, Restricted Stock, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Securities To Be Sold | Common | 05/22/2026 | Restricted Stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the ANIP Form 144 filed by Patrick Walsh report?

The filing reported two dispositions: 10,000 shares sold on 05/13/2026 for $806,300 and 3,973 shares sold on 05/11/2026 for $320,819.75. It also lists 4,336 restricted shares dated 05/22/2026 as securities to be sold.

How much cash was generated from the reported ANIP sales?

The two reported sales total $1,127,119.75 ($806,300.00 and $320,819.75) as shown in the filing. The filing does not state who received proceeds beyond the seller information provided.

What are the 4,336 shares dated 05/22/2026 in the ANIP filing?

Those are listed as Restricted Stock dated 05/22/2026 under the "Securities To Be Sold" section, with the issuer named as the source. The filing shows them as securities associated with the issuer.

Does the Form 144 indicate whether these sales were part of a trading plan?

The excerpt does not state any Rule 10b5-1 trading plan or pre-arranged sale plan. It lists sale dates, amounts, and a restricted stock entry but provides no plan or method-of-sale details.

Where is Patrick Walsh listed in the ANIP Form 144?

Patrick Walsh is identified with an address at 104 Carnegie Center Drive, Suite 300, Princeton, NJ 08540 as the reporting person tied to the two Common share dispositions shown in May 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001720568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ANI Pharmaceuticals, Inc.
SEC File Number	001-31812
Address of Issuer	104 CARNEGIE CENTER DRIVE SUITE 300 PRINCETON NEW JERSEY 08540
Phone	(609) 759-1810
Name of Person for Whose Account the Securities are To Be Sold	PATRICK WALSH
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4336	373719.84	22734618	07/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/22/2026	Restricted Stock	Issuer			4336	05/22/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK WALSH 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	05/13/2026	10000	806300.00
PATRICK WALSH 104 Carnegie Center Drive, Suite 300 Princeton NJ 08540	Common	05/11/2026	3973	320819.75

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Dennis Walsh
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)